Extramedullary multiple myeloma von Bhutani, Manisha, Foureau, David M., Atrash, Shebli, Voorhees, Peter M., Usmani, Saad Z.

Volltext

A Review of Chimeric Antigen Receptor T-Cell Therapy for Myeloma and Lymphoma von Atrash, Shebli, Moyo, Tamara K

Volltext

CAR-T treatment for hematological malignancies von Atrash, Shebli, Bano, Kulsum, Harrison, Bradley, Abdallah, Al-Ola

Volltext

Treatment patterns and outcomes according to cytogenetic risk stratification in patients with multiple myeloma: a real-world analysis von Atrash, Shebli, Flahavan, Evelyn M., Xu, Tao, Ma, Esprit, Karve, Sudeep, Hong, Wan-Jen, Jirau-Lucca, Gilbert, Nixon, Michael, Ailawadhi, Sikander

Volltext

Clinical efficacy of retreatment of daratumumab‐based therapy (D2) in daratumumab‐refractory multiple myeloma von Abdallah, Al‐Ola, Mahmoudjafari, Zahra, Ahmed, Nausheen, Cui, Wei, Shune, Leyla, McGuirk, Joseph, Mohan, Meera, Mohyuddin, Ghulam Rehman, Afrough, Aimaz, Alkharabsheh, Omar, Atrash, Shebli

Volltext

Chimeric antigen receptor T-cells: a review on current status and future directions for relapsed/refractory multiple myeloma von Hamadeh, Issam S, Friend, Reed, Mailankody, Sham, Atrash, Shebli

Volltext

Neutralizing antibody responses against SARS‐CoV‐2 in patients with plasma cell disorders who are on active treatment after two doses of mRNA vaccination von Abdallah, Al‐Ola, Mahmoudjafari, Zahra, Atieh, Tahani, Ahmed, Nausheen, Cui, Wei, Shune, Leyla, Mohan, Meera, McGuirk, Joseph, Remker, Cassie, Foss, Margaret, Karloff, Ellie, Fitch, Heather, Atrash, Shebli

Volltext

Idecabtagene vicleucel chimeric antigen receptor T-cell therapy for relapsed/refractory multiple myeloma with renal impairment von Sidana, Surbhi, Peres, Lauren C, Hashmi, Hamza, Hosoya, Hitomi, Ferreri, Christopher, Khouri, Jack, Dima, Danai, Atrash, Shebli, Voorhees, Peter, Simmons, Gary, Sborov, Douglas W, Kalariya, Nilesh, Hovanky, Vanna, Bharadwaj, Sushma, Miklos, David, Wagner, Charlotte, Kocoglu, Mehmet H, Kaur, Gurbakhash, Davis, James A, Midha, Shonali, Janakiram, Murali, Freeman, Ciara, Alsina, Melissa, Locke, Frederick, Gonzalez, Rebecca, Lin, Yi, McGuirk, Joseph, Afrough, Aimaz, Shune, Leyla, Patel, Krina K, Hansen, Doris K

Volltext

Real-world experience of patients with multiple myeloma receiving ide-cel after a prior BCMA-targeted therapy von Ferreri, Christopher J., Hildebrandt, Michelle A. T., Hashmi, Hamza, Shune, Leyla O., McGuirk, Joseph P., Sborov, Douglas W., Wagner, Charlotte B., Kocoglu, M. Hakan, Rapoport, Aaron, Atrash, Shebli, Voorhees, Peter M., Khouri, Jack, Dima, Danai, Afrough, Aimaz, Kaur, Gurbakhash, Anderson, Larry D., Simmons, Gary, Davis, James A., Kalariya, Nilesh, Peres, Lauren C., Lin, Yi, Janakiram, Murali, Nadeem, Omar, Alsina, Melissa, Locke, Frederick L., Sidana, Surbhi, Hansen, Doris K., Patel, Krina K., Castaneda Puglianini, Omar Alexis

Volltext

Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study von Atrash, Shebli, Thompson-Leduc, Philippe, Tai, Ming-Hui, Kaila, Shuchita, Gray, Kathleen, Ghelerter, Isabelle, Lafeuille, Marie-Hélène, Lefebvre, Patrick, Rossi, Adriana

Volltext

Factors associated with refractoriness or early progression after idecabtagene vicleucel in patients with relapsed/ refractory multiple myeloma: US Myeloma Immunotherapy Consortium... von Hashmi, Hamza, Hansen, Doris K, Peres, Lauren C, Puglianini, Omar Castaneda, Freeman, Ciara, De Avila, Gabriel, Sidana, Surbhi, Shune, Leyla, Sborov, Douglas W, Davis, James, Wagner, Charlotte, Kocoglu, Mehmet H, Atrash, Shebli, Voorhees, Peter, Simmons, Gary, Ferreri, Christopher, Kalariya, Nilesh, Anderson, Jr, Larry D, Afrough, Aimaz, Dima, Danai, Khouri, Jack, McGuirk, Joseph, Locke, Fred, Baz, Rachid, Patel, Krina K, Alsina, Melissa

Volltext

Outcomes of Penta-Refractory Multiple Myeloma Patients Treated with or without BCMA-Directed Therapy von Atrash, Shebli, Mammadzadeh, Aytaj, Peng, Fulei, Alkharabsheh, Omar, Afrough, Aimaz, Cui, Wei, Mahmoudjafari, Zahra, Abdallah, Al-Ola, Hashmi, Hamza

Volltext

Bone marrow Ki‐67 index is of prognostic value in newly diagnosed multiple myeloma von Atrash, Shebli, Robinson, Myra, Taneja, Alankrita, Paul, Barry, Cassetta, Kristen, Ndiaye, Ami, Varga, Cindy, Block, Jared, Lipford, Edward H., Smith, Elton T., McCall, Chad M., Thurston, Virginia, Foureau, David, Usmani, Saad Z., Voorhees, Peter M., Bhutani, Manisha

Volltext

Comparative Meta-Analysis of Triplet vs. Quadruplet Induction Regimens in Newly Diagnosed, Treatment Naïve, Multiple Myeloma von Paul, Barry, Anwer, Faiz, Raza, Shahzad, Mammadzadeh, Aytaj, Khasawneh, Bayan, Shatnawi, Sara, McGuirk, Joseph, Ahmed, Nausheen, Mahmoudjafari, Zahra, Mushtaq, Muhammad, Abdallah, Al-Ola, Atrash, Shebli

Volltext

Daratumumab, pomalidomide and dexamethasone combination therapy in daratumumab and/or pomalidomide refractory multiple myeloma von Hussain, M. Junaid, Robinson, Myra M., Hamadeh, Issam, Arnall, Justin, Bhutani, Manisha, Atrash, Shebli, Friend, Reed, Pineda‐Roman, Mauricio, Symanowski, James T., Usmani, Saad Z., Voorhees, Peter M.

Volltext

Efficacy and Safety of Daratumumab, Pomalidomide, and Dexamethasone (DPd) Compared to Daratumumab, Bortezomib, and Dexamethasone (DVd) in Daratumumab–Naïve Relapsed Multiple Myelom... von Afrough, Aimaz, Atrash, Shebli, Paul, Barry, Ouchveridze, Evguenia, Ahmed, Nausheen, Mahmoudjafari, Zahra, Bashir, Anam, Alkharabsheh, Omar, Hashmi, Hamza, Abdallah, Al-Ola

Volltext

Carfilzomib, cyclophosphamide, and dexamethasone (KCd) for the treatment of triple‐class relapsed/refractory multiple myeloma (RRMM) von Pennipede, Dante, Mohyuddin, Ghulam Rehman, Hawkins, Ryan, Ganguly, Siddhartha, Shune, Leyla, Ahmed, Nausheen, Mohan, Meera, Cui, Wei, Mahmoudjafari, Zahra, McGuirk, Joseph, Atrash, Shebli, Abdallah, Al‐Ola

Volltext

Correction to: Treatment patterns and effectiveness of patients with multiple myeloma initiating Daratumumab across different lines of therapy: a real-world chart review study von Atrash, Shebli, Thompson-Leduc, Philippe, Tai, Ming-Hui, Kaila, Shuchita, Gray, Kathleen, Ghelerter, Isabelle, Lafeuille, Marie-Hélène, Lefebvre, Patrick, Rossi, Adriana

Volltext

Outcomes of autologous stem cell transplant for cardiac AL-amyloidosis and cardiac light chain deposition disease von Abdallah, Al-Ola A, Alapat, Daisy, Kaur, Varinder, Atrash, Shebli

Volltext

Efficacy of Selinexor in Relapsed/Refractory Multiple Myeloma (RRMM) Patients with del17p and Other High-Risk Abnormalities (A Retrospective Single-Center Study) von Ehsan, Hamid, Robinson, Myra, Voorhees, Peter M, Cassetta, Kristen, Borden, Shanice, Atrash, Shebli, Bhutani, Manisha, Varga, Cindy, Pineda-Roman, Mauricio, Friend, Reed, Paul, Barry A

Volltext